1
|
Garrido A, Guardiola M, Neira LM, Sont R, Córdova H, Cuatrecasas M, Flisikowski K, Troya J, Sanahuja J, Winogrodzki T, Belda I, Meining A, Fernández-Esparrach G. Preclinical Evaluation of a Microwave-Based Accessory Device for Colonoscopy in an In Vivo Porcine Model with Colorectal Polyps. Cancers (Basel) 2023; 15:3122. [PMID: 37370732 DOI: 10.3390/cancers15123122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 06/02/2023] [Accepted: 06/06/2023] [Indexed: 06/29/2023] Open
Abstract
BACKGROUND AND AIMS Colonoscopy is currently the most effective way of detecting colorectal cancer and removing polyps, but it has some drawbacks and can miss up to 22% of polyps. Microwave imaging has the potential to provide a 360° view of the colon and addresses some of the limitations of conventional colonoscopy. This study evaluates the feasibility of a microwave-based colonoscopy in an in vivo porcine model. METHODS A prototype device with microwave antennas attached to a conventional endoscope was tested on four healthy pigs and three gene-targeted pigs with mutations in the adenomatous polyposis coli gene. The first four animals were used to evaluate safety and maneuverability and compatibility with endoscopic tools. The ability to detect polyps was tested in a series of three gene-targeted pigs. RESULTS the microwave-based device did not affect endoscopic vision or cause any adverse events such as deep mural injuries. The microwave system was stable during the procedures, and the detection algorithm showed a maximum detection signal for adenomas compared with healthy mucosa. CONCLUSIONS Microwave-based colonoscopy is feasible and safe in a preclinical model, and it has the potential to improve polyp detection. Further investigations are required to assess the device's efficacy in humans.
Collapse
Affiliation(s)
| | | | | | | | - Henry Córdova
- Endoscopy Unit, Gastroenterology Department, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain
- Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), 28029 Madrid, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain
| | - Miriam Cuatrecasas
- Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), 28029 Madrid, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain
- Facultat de Medicina i Ciències de la Salut, University of Barcelona, 08036 Barcelona, Spain
- Pathology Department, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain
| | - Krzysztof Flisikowski
- Lehrstuhl für Biotechnologie der Nutztiere, School of Life Sciences, Technische Universität München, 80333 München, Germany
| | - Joel Troya
- Interventional and Experimental Endoscopy (InExEn), Gastroenterology, Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany
| | - Josep Sanahuja
- Anesthesiology Department, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain
| | - Thomas Winogrodzki
- Lehrstuhl für Biotechnologie der Nutztiere, School of Life Sciences, Technische Universität München, 80333 München, Germany
| | | | - Alexander Meining
- Interventional and Experimental Endoscopy (InExEn), Gastroenterology, Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany
| | - Glòria Fernández-Esparrach
- MiWEndo Solutions S.L., 08014 Barcelona, Spain
- Endoscopy Unit, Gastroenterology Department, Hospital Clínic, University of Barcelona, 08036 Barcelona, Spain
- Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), 28029 Madrid, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain
- Facultat de Medicina i Ciències de la Salut, University of Barcelona, 08036 Barcelona, Spain
| |
Collapse
|
2
|
Winogrodzki T, Metwaly A, Grodziecki A, Liang W, Klinger B, Flisikowska T, Fischer K, Flisikowski K, Steiger K, Haller D, Schnieke A. TNF ΔARE pigs: a translational Crohn`s Disease model. J Crohns Colitis 2023:7055317. [PMID: 36821422 DOI: 10.1093/ecco-jcc/jjad034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Indexed: 02/24/2023]
Abstract
BACKGROUND AND AIMS Crohn's Disease (CD) is a major subtype of inflammatory bowel diseases (IBD) with increasing incidence and prevalence. Results of studies using available small and large animal models are often poorly translatable to patients, and few CD models show small intestinal pathology. Due to its similarities to humans, the swine has emerged as a highly suitable translational disease model, particularly for testing novel nutritional and technological interventions. Our goal was to develop a physiologically relevant porcine CD model to facilitate translation of findings and interventions towards the clinic. METHODS We generated pigs bearing a 93 bp deletion of the adenosine-uracil-rich element (ARE) and a constitutive-decay element within the 3'UTR of the TNF gene. Comparative analysis of physiological, molecular, histological and microbial characteristics was performed between wild-type, TNF ΔARE/+ and TNF ΔARE/ΔARE animals. Alterations in the microbiome were compared to the TNFΔARE mouse model and IBD patients. RESULTS TNF ΔARE pigs recapitulate major characteristics of human CD, including ulcerative transmural ileocolitis, increased abundance of proinflammatory cytokines, immune cell infiltration, and dysbiotic microbial communities. 16s rRNA gene amplicon sequencing revealed enrichment in members belonging to Megasphaera, Campylobacter, Desulfovibrio, Alistipes, and Lachnoclostridum in faecal or mucosa-associated bacteria compared to wild-type littermates. PCA-clustering with a subset of TNFΔARE/+ mice and human IBD patients suggests microbial similarity based on disease severity. CONCLUSIONS We demonstrate that the TNFΔARE pig resembles a CD-like ileocolitis pathophenotype recapitulating human disease. The ability to conduct long-term studies and test novel surgical procedures and dietary interventions in a physiologically relevant model will benefit future translational IBD research studies.
Collapse
Affiliation(s)
- Thomas Winogrodzki
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Amira Metwaly
- Chair of Nutrition and Immunology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Alessandro Grodziecki
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Wei Liang
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Bernhard Klinger
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Tatiana Flisikowska
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Konrad Fischer
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Krzysztof Flisikowski
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Katja Steiger
- Comparative Experimental Pathology, Institute of Pathology, Technical University of Munich, Munich, Germany
| | - Dirk Haller
- Chair of Nutrition and Immunology, School of Life Sciences, Technical University of Munich, Freising, Germany
| | - Angelika Schnieke
- Chair of Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Freising, Germany
| |
Collapse
|
3
|
Preisinger D, Winogrodzki T, Klinger B, Schnieke A, Rieblinger B. Genome Editing in Pigs. Methods Mol Biol 2023; 2631:393-417. [PMID: 36995680 DOI: 10.1007/978-1-0716-2990-1_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]
Abstract
The generation of genetically engineered (GE) pigs for disease modeling and xenotransplantation has been massively facilitated by the discovery of the CRISPR/Cas9 system. For livestock, genome editing is a powerful tool when used in combination with either somatic cell nuclear transfer (SCNT) or microinjection (MI) into fertilized oocytes. To generate either knockout or knock-in animals using SCNT, genome editing is carried out in vitro. This has the advantage that fully characterized cells are being employed to generate cloned pigs, predetermining their genetic makeups. However, this technique is labor-intensive and, hence, SCNT is better suited for more challenging projects such as the generation of multi-knockout- and knock-in pigs. Alternatively, CRISPR/Cas9 is introduced directly into fertilized zygotes via microinjection to produce knockout pigs more rapidly. Finally, the embryos are each transferred into recipient sows to deliver GE piglets.Both techniques, SCNT and MI, are technically challenging and therefore require skilled expertise, especially when applied for porcine embryos. Here, we present a detailed laboratory protocol for the generation of knockout and knock-in porcine somatic donor cells for SCNT and knockout pigs via microinjection. We describe the state-of-the-art method for isolation, cultivation, and manipulation of porcine somatic cells, which can then be used for SCNT. Moreover, we describe the isolation and maturation of porcine oocytes, their manipulation by microinjection, and the embryo transfer into surrogate sows.
Collapse
Affiliation(s)
- David Preisinger
- Department of Animal Sciences, School of Life Sciences Weihenstephan, Technical University Munich, Freising, Germany
| | - Thomas Winogrodzki
- Department of Animal Sciences, School of Life Sciences Weihenstephan, Technical University Munich, Freising, Germany
| | - Bernhard Klinger
- Department of Animal Sciences, School of Life Sciences Weihenstephan, Technical University Munich, Freising, Germany
| | - Angelika Schnieke
- Department of Animal Sciences, School of Life Sciences Weihenstephan, Technical University Munich, Freising, Germany
| | - Beate Rieblinger
- Department of Animal Sciences, School of Life Sciences Weihenstephan, Technical University Munich, Freising, Germany.
| |
Collapse
|
4
|
Flisikowski K, Perleberg C, Niu G, Winogrodzki T, Bak A, Liang W, Grodziecki A, Zhang Y, Pausch H, Flisikowska T, Klinger B, Perkowska A, Kind A, Switonski M, Janssen KP, Saur D, Schnieke A. Wild-type APC Influences the Severity of Familial Adenomatous Polyposis. Cell Mol Gastroenterol Hepatol 2021; 13:669-671.e3. [PMID: 34774804 PMCID: PMC8777002 DOI: 10.1016/j.jcmgh.2021.11.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 10/26/2021] [Accepted: 11/01/2021] [Indexed: 02/07/2023]
Affiliation(s)
- Krzysztof Flisikowski
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich, Germany
| | - Carolin Perleberg
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany; Center of Integrated Protein Science Munich, Division of Clinical Pharmacology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
| | - Guanglin Niu
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Thomas Winogrodzki
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Agnieszka Bak
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Wei Liang
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Alessandro Grodziecki
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Yue Zhang
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | | | - Tatiana Flisikowska
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Bernhard Klinger
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Anna Perkowska
- Department of Genetics and Animal Breeding, Poznan University of Life Sciences, Poznan, Poland
| | - Alexander Kind
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich Germany
| | - Marek Switonski
- Department of Genetics and Animal Breeding, Poznan University of Life Sciences, Poznan, Poland
| | - Klaus-Peter Janssen
- Department of Surgery, School of Medicine, Technical University of Munich, Munich, Germany
| | - Dieter Saur
- Translational Cancer Research and Institute for Experimental Cancer Therapy, School of Medicine, Technical University of Munich, Munich, Germany; Department of Internal Medicine II, School of Medicine, Technical University of Munich, Munich, Germany; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany
| | - Angelika Schnieke
- Livestock Biotechnology, School of Life Sciences, Technical University of Munich, Munich, Germany; ZIEL Institute for Food and Health, School of Life Sciences, Technical University of Munich, Munich, Germany
| |
Collapse
|